Suppr超能文献

白内障手术中前房内注射利多卡因后的全身血药浓度

Systemic levels of lidocaine after intracameral injection during cataract surgery.

作者信息

Wirbelauer C, Iven H, Bastian C, Laqua H

机构信息

Augenklinik, Medizinische Universität zu Lübeck, Germany.

出版信息

J Cataract Refract Surg. 1999 May;25(5):648-51. doi: 10.1016/s0886-3350(99)00005-x.

Abstract

PURPOSE

To evaluate the systemic concentrations of lidocaine after intracameral injection of a 1% solution during cataract surgery and the safety of this application mode.

SETTING

Department of Ophthalmology, Medical University of Lübeck, Lübeck, Germany.

METHODS

This prospective study included 10 patients who had phacoemulsification and posterior chamber lens implantation with a self-sealing scleral tunnel incision. Topical anesthesia was achieved using cocaine 10% eyedrops combined with 0.5mL of unpreserved lidocaine 1% injected into the anterior chamber. Blood samples were taken from all patients at predetermined intervals before and during the procedure. Consecutive analysis for lidocaine was performed with gas chromatography.

RESULTS

In all samples, serum lidocaine concentrations were below a minimum detectable level of 100 ng/mL. No local or systemic intraoperative or postoperative complications were noted.

CONCLUSIONS

Intracameral injection of 0.5 mL lidocaine 1% revealed no systemic therapeutic concentrations. In patients in whom other forms of needle-delivered local anesthesia are contraindicated, intracameral injection of lidocaine should be considered to enhance topical anesthesia.

摘要

目的

评估白内障手术期间前房内注射1%利多卡因溶液后的全身血药浓度以及这种给药方式的安全性。

地点

德国吕贝克吕贝克医科大学眼科。

方法

这项前瞻性研究纳入了10例行超声乳化白内障吸除术及后房型人工晶状体植入术并采用自闭式巩膜隧道切口的患者。使用10%可卡因滴眼液联合0.5mL未加防腐剂的1%利多卡因注入前房进行表面麻醉。在手术前和手术过程中的预定时间间隔采集所有患者的血样。采用气相色谱法对利多卡因进行连续分析。

结果

在所有样本中,血清利多卡因浓度均低于最低可检测水平100 ng/mL。未观察到局部或全身术中或术后并发症。

结论

前房内注射0.5mL 1%利多卡因未显示出全身治疗浓度。对于禁忌其他形式针剂局部麻醉的患者,应考虑前房内注射利多卡因以增强表面麻醉效果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验